Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Experimental”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04775602
What this trial is testing

Experimental Study to Evaluate the Impact of 18 Fluoro-PSMA (18F-PSMA) PET / CT in the Management of Patients with Prostate Cancer.

Who this might be right for
18F-PSMAProstate Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 550
Testing effectiveness (Phase 2)Study completedNCT02658890
What this trial is testing

An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread

Who this might be right for
Advanced CancerMelanomaNon-Small Cell Lung Cancer
Bristol-Myers Squibb 627
Not applicableEnrolling By InvitationNCT00068003
What this trial is testing

Harvesting Cells for Experimental Cancer Treatments

Who this might be right for
MelanomaGastrointestinal CancerMetastatic Cancer+2 more
National Cancer Institute (NCI) 7,000
Early research (Phase 1)Looking for participantsNCT06121843
What this trial is testing

Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 187
Early research (Phase 1)Not Yet RecruitingNCT07824843
What this trial is testing

Safety Study of GMDTC Injection in Participants With Solid Tumors and Cisplatin-Induced Renal Dysfunction

Who this might be right for
Cisplatin NephrotoxicityCisplatin Adverse Reaction
Guangdong Jianersheng Pharmaceutical Technology Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT01470417
What this trial is testing

Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
University of Florida 10
Post-approval studies (Phase 4)Study completedNCT00037518
What this trial is testing

An Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer

Who this might be right for
HyperparathyroidismParathyroid Neoplasms
Amgen 46
Early research (Phase 1)Looking for participantsNCT07733674
What this trial is testing

Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Glioblastoma Multiforme (GBM)Pancreatic Ductal Adenocarcinoma (PDAC)
Radiomedix, Inc. 20
Not applicableActive Not RecruitingNCT07613125
What this trial is testing

The Effect of Locally Made Nutritional Supplementation on Cancer Cachexia in Bangladesh: A Quasi-experimental Study.

Who this might be right for
Cancer Cachexia (CC)
International Centre for Diarrhoeal Disease Research, Bangladesh 106
Testing effectiveness (Phase 2)Ended earlyNCT02470533
What this trial is testing

Transarterial Chemoembolization Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

Who this might be right for
Liver Neoplasms
Erasmus Medical Center 100
Testing effectiveness (Phase 2)WithdrawnNCT01301612
What this trial is testing

Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS)

Who this might be right for
CarcinomaAdenocarcinomaUterine Cervix Adenosquamous Carcinoma
Eurofarma Laboratorios S.A.
Testing effectiveness (Phase 2)UnknownNCT02478099
What this trial is testing

MPDL3280A-treatment-IST-UMCG

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
University Medical Center Groningen 81
Not applicableStudy completedNCT05432232
What this trial is testing

The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy

Who this might be right for
Renal CancerTumor, SolidKidney Cancer+3 more
HistoSonics, Inc. 20
Testing effectiveness (Phase 2)Temporarily pausedNCT06232044
What this trial is testing

Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
Alliance for Clinical Trials in Oncology 88
Early research (Phase 1)Study completedNCT02718443
What this trial is testing

VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma

Who this might be right for
Glioblastoma
Vaximm GmbH 14
Testing effectiveness (Phase 2)Study completedNCT01211483
What this trial is testing

Study of Erlotinib With or Without Investigational Drug (U3-1287) in Subjects With Advanced Non-small Cell Lung Cancer

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)
Daiichi Sankyo 222
Testing effectiveness (Phase 2)Study completedNCT00047879
What this trial is testing

Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomas

Who this might be right for
Glioma
National Cancer Institute (NCI) 7
Not applicableUnknownNCT01785953
What this trial is testing

Conventional and Experimental Chemotherapy With Allogeneic Transplant in Young Patients With Acute Myeloid Leukaemia

Who this might be right for
Acute Myeloid Leukemia
Azienda Ospedaliera San Giovanni Battista 300
Early research (Phase 1)Ended earlyNCT01347866
What this trial is testing

Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer

Who this might be right for
Advanced Cancer
Pfizer 105
Not applicableStudy completedNCT04720430
What this trial is testing

Blood Sample Collection for Experimental Blood Test to Track Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Thomas Jefferson University 7
Next Page